<DOC>
	<DOCNO>NCT01506843</DOCNO>
	<brief_summary>The purpose study evaluate clinical efficacy mucosal/systemic antibody response change SLIT use house dust mite allergen without bacterial extract mite-allergic child .</brief_summary>
	<brief_title>Sublingual Immunotherapy Children With Allergic Rhinitis</brief_title>
	<detailed_description>Patients allergic rhinitis without asthma select randomized double-blind , placebo-controlled trial distribute three group : DPT ( Dpt allergen extract , n=34 ) , DPT+MRB ( Dpt allergen plus mixed respiratory bacterial extract , n=36 ) , Placebo ( n=32 ) . Clinical evaluation immunological analysis carry 12 18 month treatment , include rhinitis/asthma symptom medication score , skin prick test ( SPT ) Dpt , measurements Dpt- , Der p 1- , Der p 2-specific serum IgE , IgG4 , IgG1 -specific salivary IgA .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>Clinical diagnosis allergic rhinitis Positive skin test Dermatophagoides pteronyssinus total extract Positive serum level specific IgE D. pteronyssinus extract Previous allergen immunotherapy Use antihistamines 1 week topical corticosteroid 3 week prior skin prick test Long term use systemic corticosteroid . Airway infection 30 day prior selection . Children severe asthma , malignant , cardiovascular autoimmune disease , chemotherapy immunosuppressor therapy . Users cigarette smoke Presence severe skin lesion</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>IgA antibody</keyword>
	<keyword>IgE antibody</keyword>
	<keyword>IgG1/IgG4 subclass</keyword>
	<keyword>Mite allergy</keyword>
	<keyword>Sublingual immunotherapy</keyword>
	<keyword>Saliva</keyword>
</DOC>